Systematic Targeting Of MicroPlastics (STOMP)

SOL #: ARPA-H-SOL-26-152Solicitation

Overview

Buyer

Health And Human Services
National Institutes Of Health
ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
Washington, DC, 20005, United States

Place of Performance

Washington, DC

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

Health R&D Services; Health Care Services; Experimental Development (AN13)

Set Aside

No set aside specified

Timeline

1
Posted
Apr 2, 2026
2
Submission Deadline
Jun 22, 2026, 9:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Advanced Research Projects Agency for Health (ARPA-H) has issued an Innovative Solutions Opening (ISO) for its Systematic Targeting Of MicroPlastics (STOMP) program. This initiative seeks proposals to better quantify micro- and nano-plastics (MNPs) in humans, understand their deposition mechanisms, and ultimately improve human health by developing means to limit uptake and remove MNPs from the body. ARPA-H anticipates awarding multiple Other Transaction (OT) Agreements.

Purpose & Scope

The STOMP program is structured into two 30-month phases, focusing on two primary Technical Areas (TAs):

  • TA1: Measurement
    • Develop best-in-class, standardized, validated MNP measurement techniques for animal and human samples.
    • Create novel, fast, cheap, and easy-to-use systems for quantifying MNPs in clinical human samples at scale.
    • Conduct studies to validate the correlation between MNP content in bodily fluids and tissue samples.
  • TA2: Understanding
    • Define whole body and organ system bioaccumulation and health impacts of MNPs through acute and chronic exposure studies in animal models.
    • Establish the mechanistic framework for MNP trafficking and toxicity at the cellular and subcellular level.
  • TA3: Removal will be addressed in a subsequent solicitation.

Contract Details

  • Type: Innovative Solutions Opening (ISO) leading to Multiple Other Transaction (OT) Agreements.
  • Duration: Two 30-month phases.
  • Set-Aside: This is an open competition, eligible for universities, non-profit organizations, small businesses, and other than small businesses. Federally Funded Research and Development Centers (FFRDCs) and other Government Entities are prohibited from participating as prime or sub-performers. ARPA-H prioritizes awards to entities conducting work in the United States.
  • Place of Performance: Washington, DC, United States.

Submission & Deadlines

  • Questions & Answers Due: May 4, 2026, 5:00 PM ET
  • Solution Summaries Due: May 6, 2026, 5:00 PM ET
  • Full Proposals Due: June 22, 2026, 5:00 PM ET
  • Submission Method: Via the ARPA-H Solution Submission Portal.
  • Required Attachments: Proposers are strongly encouraged to use the provided templates for the Preliminary Task Description Document (TDD) and the Cost Proposal Spreadsheet. A sample OT Agreement is also available for review.

Evaluation Criteria

Proposals will be evaluated based on three criteria: Overall Scientific and Technical Merit, Proposer's Capabilities and/or Related Experience, and Assessment of Proposed Cost/Price.

Additional Notes

Proposers must have an active registration in SAM.gov. Commercialization plans are required for TA1 and TA3 (when solicited) proposers. Data sharing among awardees is a requirement. Information regarding a Proposers’ Day is available under a separate Special Notice (ARPA-H-SN-26-150).

People

Points of Contact

The STOMP TeamPRIMARY

Files

Files

Download
Download
Download
Download

Versions

Version 1Viewing
Solicitation
Posted: Apr 2, 2026
Systematic Targeting Of MicroPlastics (STOMP) | GovScope